postmarket

Magnifying glass copy

TGA Publishes updated MDIR Guide

By Grant Bennett | 31 October 2019
Last week, the Australian regulator, the Therapeutic Goods Administration (TGA) published an updated guidance for Australian Sponsors and Manufacturers for the reporting of adverse events in Australia (Medical device incident...
Gandalf

New Zealand WANDers towards increased device regulation

By Arthur Brandwood | 21 December 2018
If you are WANDering about the title of this blog, yes, it’s a dreadful pun I know – but it’s that time of year. New Zealand’s Medsafe have issued a...
Uncertainty

Risk vs. Benefit FDA guidance gets to grips with uncertainty

By Arthur Brandwood | 27 September 2018
Doing risk management in an uncertain world is why regulatory affairs are as much art as science. Innovators will continue to push the envelope of the possible while regulators will...

Search

Recent Posts

Gas Pathways – ISO 18562 progress

Aug 20, 2021

When is a Standard Actually a Standard?

Jul 26, 2021

The bio pharmacy: market authorisations for protein-based medicines

Jul 12, 2021

Update on Notified Bodies designation under MDR / IVDR

Jul 2, 2021

MR Compatibility and Materials Science

Jul 1, 2021

Australia’s TGA releases updated Essential Principles Checklist

May 27, 2021

Categories

Categories

Archives

Archives

Archives

Tags

510(k) ARTG Australia Biocompatibility Brexit CE China clinical evidence clinical trials Conformity Assessment coronavirus COVID-19 COVID19 Drug EU Europe FDA guidance IVD IVDD IVDR IVDs MDD MDR MDSAP medical device Medical Device Regulations medical devices Medicine medicines MHRA NMPA Notified Bodies Pharmaceutical PMA postmarket Reform Registrations regulatory Reimbursement SaMD Software Software as a Medical Device (SaMD) standards TGA